{
    "code": "12011127",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=12011127",
    "time": "2015-08-22 17:55:35",
    "許可證字號": "內衛藥製字第011127號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "106\/12\/31",
    "發證日期": "59\/10\/05",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY01201112702",
    "中文品名": "血路平片２５公絲",
    "英文品名": "HYDROPINE TABLETS 25MG \"N.Y.\"",
    "適應症": "高血壓",
    "劑型": "110錠劑",
    "包裝": "瓶裝",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "主成分略述": "RESERPINE, HYDROCHLOROTHIAZIDE (EQ TO 3,4-DIHYDROCHLOROTHIAZIDE)",
    "限制項目": [
        "09委託製造"
    ],
    "申請商名稱": "0201504200  人人化學製藥股份有限公司",
    "申請商地址": "桃園市中壢區南園二路３號",
    "主製造廠": {
        "製造廠名稱": "0201504300  人人化學製藥股份有限公司中壢廠",
        "製造廠廠址": "中壢市中壢工業區南園二路３號",
        "製造廠公司地址": "",
        "製造廠國別": "TAIWAN",
        "製程": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2408003000",
            "成分名稱": "RESERPINE",
            "含量描述": "0.125",
            "含量": "0.1250000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "4028100600",
            "成分名稱": "HYDROCHLOROTHIAZIDE (EQ TO 3,4-DIHYDROCHLOROTHIAZIDE)",
            "含量描述": "25",
            "含量": "25.0000000000",
            "單位": "MG"
        }
    ]
}